Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rubitecan in Advanced Colorectal Cancer
NCT00005877Phase 2Unknown
- Sponsor
- Astex Pharmaceuticals
- Start
- Sep 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rubitecan in colorectal cancer (CRC), sponsored by Astex Pharmaceuticals. Status: unknown.
02
Drugs
rubitecan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00005877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005877.